Viewing Study NCT05947188



Ignite Creation Date: 2024-05-06 @ 7:14 PM
Last Modification Date: 2024-10-26 @ 3:03 PM
Study NCT ID: NCT05947188
Status: RECRUITING
Last Update Posted: 2024-02-05
First Post: 2023-06-27

Brief Title: Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate CancerCMNDPC
Sponsor: First Affiliated Hospital Xian Jiaotong University
Organization: First Affiliated Hospital Xian Jiaotong University

Study Overview

Official Title: A Prospective Multicenter Cohort Study for Non-invasive Diagnosis of Prostate Cancer In Vivo Isolation of Circulating Tumor Cells Plus Multimodal MRI
Status: RECRUITING
Status Verified Date: 2023-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CMNDPC
Brief Summary: This trial is a prospective multicentre diagnostic study This study aims to evaluation the early diagnostic ability of circulating tumor cells plus multimodal MRI for prostate cancer
Detailed Description: This trial is a prospective multicentre diagnostic study This study aims to evaluation the early diagnostic ability of circulating tumor cells plus multimodal MRI for prostate cancer

We will enroll 808 men with clinical suspicion of prostate cancer due to higher level PSA4ngmlor other examination abnormal All the participants will receive prostate biopsythe circulating tumor cellsCTCswill be detected before biopsy

This study will evaluate the diagnostic ability of CTCsMRI and CTCsMRIPSAincluding sensitivity specificity predictive values diagnostic accuracy and receiver operating curvesROC

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None